SHERYL CAMPBELL-JULIEN: Open Payments
NPI 1740653583 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 56 payments from 12 companies in 2025. Trend: 2023 $321 · 2024 $1,337 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $375 |
| ABBVIE INC. | 13 | $246 |
| Alkermes, Inc. | 6 | $197 |
| Otsuka America Pharmaceutical, Inc. | 12 | $179 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: FANAPT, VRAYLAR, VIVITROL, BREZTRI, REXULTI, UZEDY, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
